Market Newsdesk

NEW YORK
, Nov. 26, 2025 /PRNewswire/ — 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline.

So what: If you purchased aTyr Pharma common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy of Efzofitimod, particularly, the drug’s capability to allow a patient to completely taper their steroid usage.

When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/atyr-deadline-atyr-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-atyr-pharma-inc-securities-fraud-lawsuit-302626164.html

SOURCE THE ROSEN LAW FIRM, P. A.

NEW YORK
, Nov. 26, 2025 /PRNewswire/ — Omnicom (NYSE: OMC) today announced that its Board of Directors increased the corporation’s quarterly dividend to $0.80 per outstanding share of common stock, or $3.20 per outstanding share of common stock on an annual basis. This reflects a $0.10 and $0.40 per share increase, respectively, versus the corporation’s prior quarterly and annual dividends. The increased quarterly dividend was declared by the Board of Directors and is payable on January 9, 2026 to shareholders of record of Omnicom common stock at the close of business on December 19, 2025.

About Omnicom
Omnicom (NYSE: OMC) is the world’s leading marketing and sales company, built for intelligent growth in the next era. Powered by Omni, Omnicom’s Connected Capabilities unite the company’s world-class agency brands, exceptional talent and deep domain expertise across media, commerce, precision marketing, advertising, production, health, public relations, branding and experiential to address clients’ critical growth priorities and deliver sustainable growth. For more information, visit www.omc.com. 

View original content:https://www.prnewswire.com/news-releases/omnicom-increases-quarterly-dividend-to-0-80-per-share-302627161.html

SOURCE Omnicom Group Inc.

BUENOS AIRES, Argentina
, Nov. 26, 2025 /PRNewswire/ — Banco Macro S.A. (NYSE: BMA; BYMA: BMA) (“Banco Macro” or “BMA” or the “Bank”) announced today its results for the third quarter ended September 30, 2025 (“3Q25”).  All figures are in Argentine pesos (Ps.) and have been restated in terms of the measuring unit current at the end of the reporting period. For ease of comparison, figures of previous quarters of 2024 have been restated applying IAS 29 to reflect the accumulated effect of the inflation adjustment for each period through September 30, 2025.

Summary

• IN THE FIRST 9 MONTHS OF 2025 (“9M25”) THE BANK’S NET INCOME totaled Ps.176.7 billion. This result was 35% or Ps.95.2 billion lower than the result posted in the same period of last year. As of 3Q25, the accumulated annualized return on average equity (“ROAE”) and the accumulated annualized return on average assets (“ROAA”) were 4.5% and 1.3%, respectively.
• In 9M25, OPERATING INCOME (after G&A and personnel expenses) totaled Ps.1.03 trillion, 64% or Ps.1.84 trillion lower than in 9M24.
• In 3Q25, BANCO MACRO’S TOTAL FINANCING increased 3% or Ps.332.4 billion quarter over quarter (“QoQ”) totaling Ps.10.12 trillion and increased 69% or Ps.4.13 trillion year over year (“YoY”). In 3Q25 USD financing increased 10% while peso financing decreased 2%..
• In 3Q25, BANCO MACRO’S TOTAL DEPOSITS increased 5% or Ps.556.4 billion QoQ and increased 11% or Ps.1.17 trillion YoY, totaling Ps.11.81 trillion and representing 75% of the Bank’s total liabilities. Private sector deposits increased 6% or Ps.604.9 billion QoQ. In 3Q25, Peso deposits decreased 1% while USD deposits increased 3%.
• Banco Macro continued showing a strong solvency ratio, with an EXCESS CAPITAL of Ps.3.30 trillion, 29.9% Capital Adequacy Ratio – Basel III and 29.2% Tier 1 Ratio. In addition, the Bank’s LIQUID ASSETS remained at an adequate level, reaching 67% of its total deposits in 3Q25.
• In 3Q25, the Bank’s NON-PERFORMING TO TOTAL FINANCING RATIO was 3.19% and the COVERAGE RATIO reached 120.87%.
• As of 3Q25, through its 469 branches and 8,811 employees Banco Macro serves 6.29 million retail customers (2.5 million digital customers) across 23 of the 24 Provinces in Argentina and over 219,235 corporate customers.

3Q25 Earnings Release Conference Call




Monday, December 1, 2025

Time: 11:00 a.m. Eastern Time | 1:00 p.m. Buenos Aires Time

To participate, please register here:

Banco Macro 3Q25 Earnings Call

IR Contacts in Buenos Aires



:

Jorge Scarinci




Chief Financial Officer

Nicolás A. Torres



Investor Relations

Phone: (54 11) 5222 6682



E-mail: [email protected]

Visit our website at:



www.macro.com.ar/relaciones-inversores

View original content:https://www.prnewswire.com/news-releases/banco-macro-announces-results-for-the-third-quarter-of-2025-302627163.html

SOURCE Banco Macro S.A.

Company to Showcase Fully Reengineered Portfolio; Executive Team, Including Head of Sales John Monds, Available for On-Site Meetings

LOS ANGELES
, Nov. 26, 2025 /PRNewswire/ — Ispire Technology Inc. (NASDAQ: ISPR) (“Ispire,” or the “Company”), announced that it will unveil its fully reengineered cannabis product ecosystem at MJBizCon 2025, the world’s largest cannabis industry conference and trade show. Held December 2–5 at the Las Vegas Convention Center, the event will serve as the official launchpad for Ispire’s next-generation hardware suite.

At the heart of this launch is Ispire’s newly structured product architecture, which is designed to offer a smarter, more intuitive way for cannabis brands to navigate hardware selection. With a clean coding system, streamlined feature sets and clearly defined use cases, the new ecosystem enables faster product discovery, confident comparisons and optimal matching with each customer’s formulation and performance needs.

“We’re making it easier than ever for brands to identify the right hardware with total clarity, premium materials and engineering that’s ready for global compliance,” said Michael Wang, Co-CEO of Ispire. “This is about elevating the customer experience while reinforcing our position as the innovation leader in the cannabis vaping sector.”

Ispire’s new suite of cannabis devices include:

The E-Series (Essentials)

: streamlined, scalable hardware for everyday formulations

• EA02-10-S – A compact, draw-activated device with a streamlined profile, voltage tuning and optimized airflow—ideal for quick customization and ease of use.
• EA03-10-S – A mid-sized model combining sleek aesthetics with increased tank volume and dual voltage control, built for brands that prioritize both form and function.
• EA04-10-S/O – Engineered for high-viscosity oils, with advanced heating elements and a self-sealing tank that minimizes leakage while preserving terpene integrity—perfect for extract-focused brands.

The S-Series (Specialized)

: advanced, high-performance solutions for premium oils and technical requirements

• SA05-10-S – The flagship model featuring dual activation (draw/button), extended battery life and high-end construction. Ideal for premium positioning and brand differentiation.
• SA03-10-S/O – A versatile postless disposable device featuring puff-sense activation, clog-proof engineering and dual-sided tank windows for optimal visibility. The self-sealing fill system enhances reliability and leak resistance, while the compact form factor and 270mAh battery deliver consistency for brands targeting high-volume, user-friendly applications.
• SA04-10-S/O – Built for durability and discretion, this self-sealing, single-use model balances premium feel with a minimalist footprint. Designed for consistent dosing, fast activation and simplified logistics, it’s ideal for regulated markets or product lines prioritizing compliance, portability and minimal waste.

The C-Series (Custom)

: fully custom and ODM-engineered devices built from the ground up

• For brands seeking complete differentiation, the C-Series enables fully custom, ODM-engineered hardware solutions tailored to proprietary aesthetics, heating technologies, materials, form factors, performance targets or market-specific certifications. Whether adapting an existing platform or developing a device from scratch, the C-Series provides end-to-end product development support aligned with Ispire’s quality and compliance standards.

Each new device reflects Ispire’s core principles of efficiency, safety and design simplicity. Built with world-class components and aligned with the company’s precision dosing mission, the portfolio supports a wide spectrum of cannabis oil viscosities, fill volumes and activation types, including draw, button and dual-mode configurations.

“We engineer it. You own it,” added Wang. “This architecture gives our partners the freedom to build their own brands and stories, while we provide the foundation of reliability, performance and regulatory readiness.”

Senior executives, including John Monds, Vice President of Sales, will be available for meetings throughout MJBizCon 2025. Attendees interested in exploring Ispire’s new platform or discussing partnership opportunities can schedule time directly by emailing [email protected].

About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company’s operating subsidiaries own or license more than 400 patents worldwide. Ispire’s branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People’s Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company’s cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, X and YouTube.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company will be successful in its plans to further expand into the African market; whether the Company’s joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the “Joint Venture”) may be successful in achieving its goals as currently contemplated, with different terms, or at all; the Joint Venture’s ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company’s ability to collect its accounts receivable in a timely manner; the Company’s business strategies; the ability of the Company to market to the Ispire ONE™; Ispire ONE™’s success in meeting its goals; the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of its products on the markets; the Ispire ONE™ proving to be safe; and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Cautionary Note on Forward-Looking Statements” and the additional risk described in Ispire’s Annual Report on Form 10-K for the year ended June 30, 2025 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

IR Contact:

Phil Carlson

+1-212-896-1233
[email protected]

PR Contact:

Ellen Mellody

+1-570-209-2947
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/ispire-technology-unveils-next-gen-cannabis-hardware-ecosystem-at-mjbizcon-2025-302627159.html

SOURCE Ispire Technology Inc.

NEW YORK
, Nov. 26, 2025 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the “Fund”) with information regarding the sources of the distribution to be paid on November 28, 2025 and cumulative distributions paid fiscal year-to-date.

In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund’s long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital gains throughout the year and to distribute those gains on a regular monthly basis to shareholders. The Board of Directors of the Fund may amend, terminate or suspend the managed distribution policy at any time, which could have an adverse effect on the market price of the Fund’s shares. 

The Fund’s monthly distributions may include long-term capital gains, short-term capital gains, net investment income and/or return of capital for federal income tax purposes. Return of capital includes distributions paid by the Fund in excess of its net investment income and net realized capital gains and such excess is distributed from the Fund’s assets. A return of capital is not taxable; rather, it reduces a shareholder’s tax basis in his or her shares of the Fund. In addition, distributions from the Fund’s investments in real estate investment trusts (REITs) may later be characterized as capital gains and/or a return of capital, depending on the character of the dividends reported to the Fund after year-end by REITs held by the Fund. The amount of monthly distributions may vary depending on a number of factors, including changes in portfolio and market conditions.

At the time of each monthly distribution, information will be posted to cohenandsteers.com and mailed to shareholders in a concurrent notice. However, this information may change at the end of the year because the final tax characteristics of the Fund’s distributions cannot be determined with certainty until after the end of the calendar year. Final tax characteristics of all of the Fund’s distributions will be provided on Form 1099-DIV, which is mailed after the close of the calendar year.

The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year-to-date from the sources indicated. All amounts are expressed per common share.

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy. The Fund estimates that it has distributed more than its income and capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with ‘yield’ or ‘income’. The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of distributions year-to-date may be subject to additional adjustments.

*THE FUND WILL SEND YOU A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES.

The Fund’s Year-to-date Cumulative Total Return for fiscal year 2025 (January 1, 2025 through October 31, 2025) is set forth below. Shareholders should take note of the relationship between the Year-to-date Cumulative Total Return with the Fund’s Cumulative Distribution Rate for 2025. In addition, the Fund’s Average Annual Total Return for the five-year period ending October 31, 2025 is set forth below. Shareholders should note the relationship between the Average Annual Total Return with the Fund’s Current Annualized Distribution Rate for 2025. The performance and distribution rate information disclosed in the table is based on the Fund’s net asset value per share (NAV). The Fund’s NAV is calculated as the total market value of all the securities and other assets held by the Fund minus the total liabilities, divided by the total number of shares outstanding. While NAV performance may be indicative of the Fund’s investment performance, it does not measure the value of a shareholder’s individual investment in the Fund. The value of a shareholder’s investment in the Fund is determined by the Fund’s market price, which is based on the supply and demand for the Fund’s shares in the open market.

Fund Performance and Distribution Rate Information:

Investors should consider the investment objectives, risks, charges and expense of the Fund carefully before investing. You can obtain the Fund’s most recent periodic reports, when available, and other regulatory filings by contacting your financial advisor or visiting cohenandsteers.com. These reports and other filings can be found on the Securities and Exchange Commission’s EDGAR Database. You should read these reports and other filings carefully before investing.

Shareholders should not use the information provided here in preparing their tax returns. Shareholders will receive a Form 1099-DIV for the calendar year indicating how to report Fund distributions for federal income tax purposes.

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.  

Forward-Looking Statements


This press release and other statements that Cohen & Steers may make may contain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which reflect the company’s current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” or the negative versions of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties.

Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

Website: https://www.cohenandsteers.com
Symbol: (NYSE: CNS)

View original content:https://www.prnewswire.com/news-releases/cohen–steers-total-return-realty-fund-inc-rfi-notification-of-sources-of-distribution-under-section-19a-302627157.html

SOURCE Cohen & Steers, Inc.